tiprankstipranks
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
Holding AVIR?
Track your performance easily

Atea Pharmaceuticals (AVIR) Cash flow

209 Followers

Atea Pharmaceuticals Cash Flow

AVIR's free cash flow for Q3 2024 was $-23.04M. For the 2024 fiscal year, AVIR's free cash flow was decreased by $37.53M and operating cash flow was $-23.04M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -126.94M$ -85.39M$ -120.98M$ -87.00M$ 296.73M$ -12.83M
Investing Cash Flow
$ 87.25M$ 40.30M$ -455.41M$ -4.00K$ -26.00K$ -2.00K
Financing Cash Flow
$ 267.00K$ 257.00K$ 370.00K$ 1.47M$ 531.75M$ 0.00
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 646.59M$ 143.82M$ 188.66M$ 764.68M$ 850.22M$ 21.77M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 267.00K$ 257.00K$ 140.00K$ 1.47M$ 317.63M$ 0.00
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -105.10M$ -85.39M$ -122.92M$ -87.01M$ 296.71M$ -12.83M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Atea Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis